This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Metabolic disorders
Metabolic disorders
Sanofi licenses new diabetes drug
Diabetes pill trial shows promise
Boehringer Ingelheim’s diabetes pipeline continues to advance
European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines on parenteral nutrition
Is there a need for testosterone replacement therapy in older men?
Diabetes drug linked to heart failure
FDA approves Onglyza diabetes drug
Launch of Victoza to treat type 2 diabetes
Cannabis used in diabetes medicine
Diabetes drug linked to cancer care
Once-daily diabetes drug recommended for approval
Amylin seeks approval for diabetes jab
« Previous
1
…
6
7
8
9
10
…
14
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: